Biological Evaluation of Boron for Health Science for Research Purpose
Louis Pasteur Center for Medical Research
Project Concept
BNCT effect for malignant brain tumors has been still controversial, and investigation for further effective boron/gadolinium compounds (B-com) has been expected national wide for accelerator based BNCT of Cancer. To promote this investigation, we will accademically provide quick bio-assay of new boron compounds for BNCT with easy access and low academic price. The project is supported by motivation and enthusiasm for BNCT of Kyoto University researchers for neutron irradiation experiments as well as Pasteur researchers. We hope our project might improve BNCT research for cancer patients.
Our area of research concerns are not only for BNCT, but also boronscience.
This project is supported by a visiting official program of Institute for Integrated Radiation and Nuclear Science, Kyoto University.
Dr. Mao Takagaki, MD, PhD.
She joined to the BNCT research group of Prof. Yutaka Mishima at Wakayama Medical College/Kobe University when she was a graduate student of Radiation Protection and Physics at Kyoto University, and has started to investigate BNCT for malignant melanoma from 1975. Then she joined with Neurosurgeons of Profs, Keiji Sano and Hiroshi Hatanaka, to study BNCT for malignant glioma at Tokyo University/Teikyo University as a neurosurgical resident from 1985. She got PhD at Kyoto University and engaged in BNCT basic/clinical research at Research Reactor Institute of Kyoto University (KUR) as a chief resident of Dept. Neurosurgery, Kyoto University. To study and investigate boron compounds/chemistry, she joined to Prof Narayan’s group of Northern Illinois University, DeKalb, IL, as a visiting researcher since 1990. She is still active in this research field.
